Market Overview:
The global morphine sulfat market is expected to grow at a CAGR of 3.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of chronic pain, rising demand for opioids in developed countries, and growing awareness about pain management. By type, the morphine sulfat market is segmented into pills, powder, and others. The pills segment is expected to dominate the global morphine sulfat market during the forecast period owing to its ease of use and high demand among patients suffering from chronic pain. By application, oral tablets are expected to account for a major share of the global morphine sulfat market during the forecast period as they are easy-to-use and provide relief from moderate-to-severe pain within a short time frame.
 Industry Outlook.svg)
Product Definition:
Morphine sulfate (CAS 64-31-3) is an opioid analgesic drug that is used to relieve pain. It is a derivative of morphine, and it acts by binding to the opioid receptors in the brain. This results in decreased sensation of pain, and feelings of euphoria.
Pills:
Pills, it's usage and growth factor in Morphine Sulfat (CAS 64-31-3) market is a type of chemical substance which is used to make different medications. It’s also used as an opioid analgesic which means it helps with pain. Pills, it’s usage and growth factor in Morphine Sulfat market can be segmented on the basis of source & application.
Powder:
Powder is a fine, white crystalline powder and has a slightly sweet odor. It is insoluble in water and most organic solvents. The product can be administered intramuscularly, intravenously or orally; it is preferably given by the oral route due to its better bioavailability when compared with other routes of administration.
Application Insights:
Oral tablets were the most prominent application segment and accounted for a revenue share of around 70.0% in 2017. The growing preference for oral administration over other methods such as injection is expected to be one of the key factors driving the demand for capsules over other forms such as powder or pill during the forecast period. Morphine sulfat is used in producing oral analgesic tablets that are commonly known as MS Contin, which is manufactured by Pfizer Inc., New York, U.S.
The injection segment held a significant share owing to its high efficacy.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number ofmorphine sulfat tablets manufacturers and suppliers coupled with high healthcare expenditure. The region is expected to maintain its dominance over the forecast period.
Asia Pacific is anticipated to be one of the fastest-growing regions duringthe forecast period owing to increasing demand formorphine sulfat from countries such as China, India, and Japan. In addition, rising awareness about opioid substitution therapy among patients suffering from chronic pain conditions is also expectedto drive growth in this region.
The Latin American market for morphinanucleoside analogues was estimated at USD X millionin 2016.
Growth Factors:
- Increasing demand for pain relief medications
- Rising prevalence of chronic pain conditions
- Growing geriatric population
- Increasing number of surgical procedures
- Technological advancements in drug delivery systems
Scope Of The Report
Report Attributes
Report Details
Report Title
Morphine Sulfat (CAS 64-31-3) Market Research Report
By Type
Pills, Powder
By Application
Oral Tablets, Injection, Capsule, Others
By Companies
Mallinckrodt Pharmaceuticals, Alcaliber, Purdue Pharma, Cepia-Sanofi, Macfarlan Smith, SUN PHARMA, Qinghai Pharmaceutical, Taj Pharmaceuticals, Northeast Pharm
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Morphine Sulfat (CAS 64-31-3) Market Report Segments:
The global Morphine Sulfat (CAS 64-31-3) market is segmented on the basis of:
Types
Pills, Powder
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oral Tablets, Injection, Capsule, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Mallinckrodt Pharmaceuticals
- Alcaliber
- Purdue Pharma
- Cepia-Sanofi
- Macfarlan Smith
- SUN PHARMA
- Qinghai Pharmaceutical
- Taj Pharmaceuticals
- Northeast Pharm
 Market Overview.svg)
Highlights of The Morphine Sulfat (CAS 64-31-3) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pills
- Powder
- By Application:
- Oral Tablets
- Injection
- Capsule
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Morphine Sulfat (CAS 64-31-3) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Morphine sulfat is a white to off-white solid with a characteristic odor. It is used as an analgesic and sedative agent.
Some of the major players in the morphine sulfat (cas 64-31-3) market are Mallinckrodt Pharmaceuticals, Alcaliber, Purdue Pharma, Cepia-Sanofi, Macfarlan Smith, SUN PHARMA, Qinghai Pharmaceutical, Taj Pharmaceuticals, Northeast Pharm.
The morphine sulfat (cas 64-31-3) market is expected to grow at a compound annual growth rate of 3.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Morphine Sulfat (CAS 64-31-3) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Morphine Sulfat (CAS 64-31-3) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Morphine Sulfat (CAS 64-31-3) Market - Supply Chain
4.5. Global Morphine Sulfat (CAS 64-31-3) Market Forecast
4.5.1. Morphine Sulfat (CAS 64-31-3) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Morphine Sulfat (CAS 64-31-3) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Morphine Sulfat (CAS 64-31-3) Market Absolute $ Opportunity
5. Global Morphine Sulfat (CAS 64-31-3) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Morphine Sulfat (CAS 64-31-3) Market Size and Volume Forecast by Type
5.3.1. Pills
5.3.2. Powder
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Morphine Sulfat (CAS 64-31-3) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Morphine Sulfat (CAS 64-31-3) Market Size and Volume Forecast by Application
6.3.1. Oral Tablets
6.3.2. Injection
6.3.3. Capsule
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Morphine Sulfat (CAS 64-31-3) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Morphine Sulfat (CAS 64-31-3) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Morphine Sulfat (CAS 64-31-3) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Morphine Sulfat (CAS 64-31-3) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Morphine Sulfat (CAS 64-31-3) Demand Share Forecast, 2019-2026
9. North America Morphine Sulfat (CAS 64-31-3) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Morphine Sulfat (CAS 64-31-3) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Morphine Sulfat (CAS 64-31-3) Market Size and Volume Forecast by Application
9.4.1. Oral Tablets
9.4.2. Injection
9.4.3. Capsule
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Morphine Sulfat (CAS 64-31-3) Market Size and Volume Forecast by Type
9.7.1. Pills
9.7.2. Powder
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Morphine Sulfat (CAS 64-31-3) Demand Share Forecast, 2019-2026
10. Latin America Morphine Sulfat (CAS 64-31-3) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Morphine Sulfat (CAS 64-31-3) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Morphine Sulfat (CAS 64-31-3) Market Size and Volume Forecast by Application
10.4.1. Oral Tablets
10.4.2. Injection
10.4.3. Capsule
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Morphine Sulfat (CAS 64-31-3) Market Size and Volume Forecast by Type
10.7.1. Pills
10.7.2. Powder
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Morphine Sulfat (CAS 64-31-3) Demand Share Forecast, 2019-2026
11. Europe Morphine Sulfat (CAS 64-31-3) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Morphine Sulfat (CAS 64-31-3) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Morphine Sulfat (CAS 64-31-3) Market Size and Volume Forecast by Application
11.4.1. Oral Tablets
11.4.2. Injection
11.4.3. Capsule
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Morphine Sulfat (CAS 64-31-3) Market Size and Volume Forecast by Type
11.7.1. Pills
11.7.2. Powder
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Morphine Sulfat (CAS 64-31-3) Demand Share, 2019-2026
12. Asia Pacific Morphine Sulfat (CAS 64-31-3) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Morphine Sulfat (CAS 64-31-3) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Morphine Sulfat (CAS 64-31-3) Market Size and Volume Forecast by Application
12.4.1. Oral Tablets
12.4.2. Injection
12.4.3. Capsule
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Morphine Sulfat (CAS 64-31-3) Market Size and Volume Forecast by Type
12.7.1. Pills
12.7.2. Powder
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Morphine Sulfat (CAS 64-31-3) Demand Share, 2019-2026
13. Middle East & Africa Morphine Sulfat (CAS 64-31-3) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Morphine Sulfat (CAS 64-31-3) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Morphine Sulfat (CAS 64-31-3) Market Size and Volume Forecast by Application
13.4.1. Oral Tablets
13.4.2. Injection
13.4.3. Capsule
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Morphine Sulfat (CAS 64-31-3) Market Size and Volume Forecast by Type
13.7.1. Pills
13.7.2. Powder
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Morphine Sulfat (CAS 64-31-3) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Morphine Sulfat (CAS 64-31-3) Market: Market Share Analysis
14.2. Morphine Sulfat (CAS 64-31-3) Distributors and Customers
14.3. Morphine Sulfat (CAS 64-31-3) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Mallinckrodt Pharmaceuticals
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Alcaliber
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Purdue Pharma
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Cepia-Sanofi
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Macfarlan Smith
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. SUN PHARMA
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Qinghai Pharmaceutical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Taj Pharmaceuticals
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Northeast Pharm
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
